ot-551
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00333060)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetOTHER
Antiinflammatory, antioxidant
- Unspecified targetAntioxidant
Antioxidant
Chemistry & pharmacology
Loading structure…
SMILES
CC1(C)CC(OC(=O)C2CC2)CC(C)(C)N1O- Mol. weight
- 241.33 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Prodrug
Sources
- ChEMBLCHEMBL4297313 ↗
Also known as
- ot-551
- ot-551
- ot-551
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00485394 | Phase 2 | Jun 1, 2007 | Othera Pharmaceuticals |
| NCT00306488 | Phase 2 | Mar 1, 2006 | National Eye Institute (NEI), Othera Pharmaceuticals |
| NCT00333060 | Phase 2 | Nov 1, 2005 | Othera Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Othera Pharmaceuticals | For profit | 3 | 3 | 1 | 2005 |
| National Eye Institute (NEI) | Government | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1